Carticept Medical studies the Cartiva cartilage device versus MTP fusion in clinical study

By

Cartiva: On the Way to PMA (Orthopedics This Week)
http://www.carticept.com/cartiva.html
Cartiva, Inc. has just completed enrollment in the MOTION trial, an international, multi-center study of its Cartiva Synthetic Cartilage Implant (SCI). The results of the MOTION trial, which has enrolled 233 patients at 12 sites in Canada and the UK, are intended to establish the basis for a Premarket Approval Application (PMA) to the FDA.
The MOTION study, the largest prospective clinical trial for osteoarthritis (OA) of the first metatarsophalangeal (MTP) joint, was designed to determine the safety and e...

Get access to full posts newsletters, trends, and market reports for only subscribe for $1/day.
Hit the SUBSCRIBE button at the top of the homepage.